TEVA - Teva Pharmaceutical Industries Limited

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
17,720,000
18,854,000
22,385,000
21,903,000
19,652,000
Cost of Revenue
10,023,000
10,558,000
11,560,000
10,044,000
8,296,000
Gross Profit
7,697,000
8,296,000
10,825,000
11,859,000
11,356,000
Operating Expenses
Research Development
1,143,000
1,213,000
1,848,000
2,111,000
1,525,000
Selling General and Administrative
4,051,000
4,214,000
4,986,000
5,096,000
4,717,000
Total Operating Expenses
5,176,000
5,136,000
5,635,000
7,207,000
6,242,000
Operating Income or Loss
2,521,000
3,160,000
5,190,000
4,652,000
5,114,000
Interest Expense
-
920,000
875,000
546,000
270,000
Total Other Income/Expenses Net
-6,153,000
-4,797,000
-22,674,000
-2,498,000
-1,762,000
Income Before Tax
-4,534,000
-2,596,000
-18,379,000
824,000
2,352,000
Income Tax Expense
-335,000
-195,000
-1,933,000
521,000
634,000
Income from Continuing Operations
-4,208,000
-2,472,000
-16,449,000
311,000
1,597,000
Net Income
-3,888,000
-2,150,000
-16,265,000
329,000
1,588,000
Net Income available to common shareholders
-4,007,000
-2,399,000
-16,525,000
68,000
1,573,000
Reported EPS
Basic
-
-2.35
-16.26
0.07
1.84
Diluted
-
-2.35
-16.26
0.07
1.82
Weighted average shares outstanding
Basic
-
1,021
1,016,000
955,000
855,000
Diluted
-
1,021
1,016,000
961,000
864,000
EBITDA
-
3,160,000
5,190,000
4,652,000
5,114,000